Stock Events

Stock Events

Kaken Pharmaceutical (4521.TSE) Q4 2024 Earnings

8NovConfirmed

Q4 2023

Q2 2024

Q3 2024

Q4 2024

42

145

248

351

Details

Expected EPS

N/A

Actual EPS

351

Surprise EPS

351

Surprise Percent

+∞%

Description

Kaken Pharmaceutical (4521.TSE) has reported earnings of 351 per share for Q4 2024.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.